Experienced in Vertigo

Dr. Robert C. Martin

Internal Medicine
New Lexington Clinic
1138 Lexington Road, Suite 290, 
Georgetown, KY 

Experienced in Vertigo
New Lexington Clinic
1138 Lexington Road, Suite 290, 
Georgetown, KY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Martin is a primary care provider, practicing in Internal Medicine in Georgetown, Kentucky. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Stomach Cancer, Mesenchymoma, Fibrolamellar Carcinoma, Splenectomy, and Pancreaticoduodenectomy.

His clinical research consists of participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in KY
Hospital Affiliations
Georgetown Community Hospital
Baptist Health Lexington
Saint Joseph East
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

New Lexington Clinic
1138 Lexington Road, Suite 290, Georgetown, KY 40324
Call: 859-258-8880

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

A Phase 2b, Open-label, Single-arm Study of ZW25 Monotherapy in Subjects With Advanced or Metastatic HER2-amplified Biliary Tract Cancers
A Phase 2b, Open-label, Single-arm Study of ZW25 Monotherapy in Subjects With Advanced or Metastatic HER2-amplified Biliary Tract Cancers
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drug: ZW25 (Zanidatamab)
Study Phase: Phase 2
Comparative, Prospective, Open-labeled, Randomized Phase II Study of Cisplatin or Carboplatin With Gemcitabine in Combination With Irinotecan-loaded Beads (LC or ONCOZENE) Versus Cisplatin or Carboplatin With Gemcitabine Alone in the Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Comparative, Prospective, Open-labeled, Randomized Phase II Study of Cisplatin or Carboplatin With Gemcitabine in Combination With Irinotecan-loaded Beads (LC or ONCOZENE) Versus Cisplatin or Carboplatin With Gemcitabine Alone in the Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
Enrollment Status: Completed
Publish Date: February 27, 2025
Intervention Type: Drug, Device
Study Phase: Phase 2
Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2025
Intervention Type: Drug, Device
The Effect of FOLFIRINOX and Stereotactic Body Radiation Therapy for Locally Advanced, Non-Resectable Pancreatic Cancer
The Effect of FOLFIRINOX and Stereotactic Body Radiation Therapy for Locally Advanced, Non-Resectable Pancreatic Cancer
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Radiation, Drug
Study Drug: Folfirinox
Study Phase: Phase 2
A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
Enrollment Status: Unknown
Publish Date: March 04, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC)
A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients With Unresectable Hepatocellular Carcinoma (HCC)
Enrollment Status: Completed
Publish Date: November 08, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
A Randomized Phase II Study of Perioperative mFOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 19, 2022
Intervention Type: Drug, Procedure
Study Drugs: Fluorouracil, Gemcitabine hydrochloride, Irinotecan hydrochloride, Oxaliplatin, Paclitaxel albumin-stabilized nanoparticle formulation
Study Phase: Phase 2
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
Enrollment Status: Unknown
Publish Date: May 24, 2022
Intervention Type: Drug, Procedure, Radiation
Study Drugs: mFOLFIRINOX, FOLFOX
Study Phase: Phase 2
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
A Phase III Clinical Trial Evaluating TheraSphere® in Patients With Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Device
Study Phase: Not Applicable
Louisville Cooperative Tissue Biorepository of the James Graham Brown Cancer Center Tissue Collection Consent
Louisville Cooperative Tissue Biorepository of the James Graham Brown Cancer Center Tissue Collection Consent
Enrollment Status: Completed
Publish Date: November 10, 2021
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
A Randomized Controlled Trial of Transcatheter Arterial Chemoembolization With Drug Eluting Beads (DEB-TACE) Versus Sorafenib in the Treatment of Unresectable, Locally Advanced Hepatocellular Carcinoma
Enrollment Status: Terminated
Publish Date: February 12, 2021
Intervention Type: Device, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Open-Label Study Comparing Pexa Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy
A Phase 3 Randomized, Open-Label Study Comparing Pexa Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy
Enrollment Status: Completed
Publish Date: December 16, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 3
A Phase III, Multicenter, Open-Label, Randomized Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablated Intra-Hepatic Cholangiocarcinoma
A Phase III, Multicenter, Open-Label, Randomized Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablated Intra-Hepatic Cholangiocarcinoma
Enrollment Status: Withdrawn
Publish Date: February 19, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 12 Less Clinical Trials
Similar Doctors
Advanced in Vertigo
Dr. Stephen D. Damron
Internal Medicine
Advanced in Vertigo
Dr. Stephen D. Damron
Internal Medicine
222 Medical Cir, 
Morehead, KY 
 (112.7 miles away)
606-783-6500
Languages Spoken:
English
See accepted insurances

Stephen Damron is a primary care provider, practicing in Internal Medicine in Morehead, Kentucky. Dr. Damron is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Sepsis, Peptic Ulcer, Pneumonia, and Necrosis.

Advanced in Vertigo
Dr. David B. George
Internal Medicine
Advanced in Vertigo
Dr. David B. George
Internal Medicine

Family And Internal Medicine Associates PLLC

325 W Walnut St, 
Lebanon, KY 
 (45.1 miles away)
270-699-9500
Languages Spoken:
English
See accepted insurances

David George is a primary care provider, practicing in Internal Medicine in Lebanon, Kentucky. Dr. George is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Morning Sickness, High Cholesterol, Dehydration, and Type 2 Diabetes (T2D).

Advanced in Vertigo
Dr. Mohana R. Arla
Internal Medicine
Advanced in Vertigo
Dr. Mohana R. Arla
Internal Medicine

Bullitt County Family Practitioners Psc

170 Dr Arla Way, Suite 101, 
Louisville, KY 
 (11.8 miles away)
502-955-8480
Languages Spoken:
English
See accepted insurances

Mohana Arla is a primary care provider, practicing in Internal Medicine in Louisville, Kentucky. Dr. Arla is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Tracheitis, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Endoscopy, and Ureteroscopy.

VIEW MORE VERTIGO DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Martin's expertise for a condition
ConditionClose
      • Advanced
      • Fibrolamellar Carcinoma
        Dr. Martin is
        Advanced
        . Learn about Fibrolamellar Carcinoma.
        See more Fibrolamellar Carcinoma experts
      • Mesenchymoma
        Dr. Martin is
        Advanced
        . Learn about Mesenchymoma.
        See more Mesenchymoma experts
      • Stomach Cancer
        Dr. Martin is
        Advanced
        . Learn about Stomach Cancer.
        See more Stomach Cancer experts
      • Experienced
      • Angioedema
        Dr. Martin is
        Experienced
        . Learn about Angioedema.
        See more Angioedema experts
      • Atherosclerosis
        Dr. Martin is
        Experienced
        . Learn about Atherosclerosis.
        See more Atherosclerosis experts
      • Childhood Iron Deficiency Anemia
        Dr. Martin is
        Experienced
        . Learn about Childhood Iron Deficiency Anemia.
        See more Childhood Iron Deficiency Anemia experts
      • Cholangiocarcinoma (Bile Duct Cancer)
        Dr. Martin is
        Experienced
        . Learn about Cholangiocarcinoma (Bile Duct Cancer).
        See more Cholangiocarcinoma (Bile Duct Cancer) experts
      • Chronic Cough
        Dr. Martin is
        Experienced
        . Learn about Chronic Cough.
        See more Chronic Cough experts
      • Chronic Obstructive Pulmonary Disease (COPD)
        Dr. Martin is
        Experienced
        . Learn about Chronic Obstructive Pulmonary Disease (COPD).
        See more Chronic Obstructive Pulmonary Disease (COPD) experts
      View All 62 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request a Doctor Appointment

        Please fill out the details in the form below to allow MediFind to submit an appointment request to Dr. Robert C. Martin's office on your behalf. Your provider may contact you directly to complete scheduling. If you are experiencing a medical emergency, please call 9-1-1. This form is for appointment requests only. Currently, we are not accepting appointments from users outside of the US.

            Close

            Returning patient? Use your address on file with the provider.

            0 / 1000

            Please provide us with the below insurance information:

            Insurance Provider *
            Insurance ProviderClose
            By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.